Status:
COMPLETED
Study of Naltrexone for Methamphetamine Addiction
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
Methamphetamine Dependence
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age between 18 and 50 years
- Patient is agreeable to conditions of study and signs consent form
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00984360
Start Date
September 1 2009
End Date
September 1 2012
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addiction & Pharmacology Research Laboratory
San Francisco, California, United States, 94110